| Year |
Citation |
Score |
| 2015 |
Sheremata W, Brown AD, Rammohan KW. Dimethyl fumarate for treating relapsing multiple sclerosis. Expert Opinion On Drug Safety. 14: 161-70. PMID 25382392 DOI: 10.1517/14740338.2015.977251 |
0.362 |
|
| 2015 |
Perzova R, Graziano E, Sanghi S, Welch C, Benz P, Abbott L, Lalone D, Glaser J, Loughran T, Sheremata W, Poiesz BJ. Increased seroreactivity to human T cell lymphoma/leukemia virus-related endogenous sequence-1 Gag peptides in patients with human T cell lymphoma/leukemia virus myelopathy. Aids Research and Human Retroviruses. 31: 242-9. PMID 25295378 DOI: 10.1089/Aid.2014.0171 |
0.376 |
|
| 2014 |
Tornes L, Conway B, Sheremata W. Multiple sclerosis and the cerebellum. Neurologic Clinics. 32: 957-77. PMID 25439291 DOI: 10.1016/J.Ncl.2014.08.001 |
0.422 |
|
| 2014 |
Delgado SR, Lavi ES, Campos YA, Ortega M, Rammohan K, Sheremata WA. Natalizumab Associated PML in a Multiple Sclerosis Patient: Excellent Response to Minimal Intervention Journal of Multiple Sclerosis. 1: 1-4. DOI: 10.4172/Jmso.1000119 |
0.363 |
|
| 2013 |
Sheremata W, Tornes L. Multiple Sclerosis and the Spinal Cord Neurologic Clinics. 31: 55-77. PMID 23186896 DOI: 10.1016/J.Ncl.2012.09.007 |
0.395 |
|
| 2013 |
Sheremata WA, Sazant A, Riesgo V, Burns A. Intrathecal IgG synthesis in relapsing-remitting multiple sclerosis (MS) is decreased by natural human alpha interferon Advances in Bioscience and Biotechnology. 4: 1-5. DOI: 10.4236/Abb.2013.47A3001 |
0.38 |
|
| 2012 |
Usmani N, Bedi G, Lam BL, Sheremata WA. Association between paroxysmal tonic spasms and neuromyelitis optica. Archives of Neurology. 69: 121-4. PMID 22232353 DOI: 10.1001/Archneurol.2011.832 |
0.394 |
|
| 2011 |
Bedi GS, Brown AD, Delgado SR, Usmani N, Lam BL, Sheremata WA. Impact of rituximab on relapse rate and disability in neuromyelitis optica. Multiple Sclerosis (Houndmills, Basingstoke, England). 17: 1225-30. PMID 21622594 DOI: 10.1177/1352458511404586 |
0.367 |
|
| 2010 |
Delgado SR, Sheremata WA, Brown AD, McCarthy M. Human T-lymphotropic virus type I or II (HTLV-I/II) associated with recurrent longitudinally extensive transverse myelitis (LETM): two case reports. Journal of Neurovirology. 16: 249-53. PMID 20450377 DOI: 10.3109/13550281003801493 |
0.33 |
|
| 2009 |
Delgado S, Baez S, Singer C, Sengun C, Sheremata WA, Papapetropoulos S. Parkinsonism/dystonia syndrome secondary to multiple sclerosis with anti-basal-ganglia antibodies. Movement Disorders : Official Journal of the Movement Disorder Society. 24: 309-11. PMID 18951536 DOI: 10.1002/Mds.22331 |
0.332 |
|
| 2008 |
Sheremata WA, Jy W, Horstman LL, Ahn YS, Alexander JS, Minagar A. Evidence of platelet activation in multiple sclerosis. Journal of Neuroinflammation. 5: 27. PMID 18588683 DOI: 10.1186/1742-2094-5-27 |
0.397 |
|
| 2008 |
Sharma KR, Saadia D, Facca AG, Bhatia R, Ayyar DR, Sheremata W. Chronic inflammatory demyelinating polyradiculoneuropathy associated with multiple sclerosis. Journal of Clinical Neuromuscular Disease. 9: 385-396. PMID 18525422 DOI: 10.1097/Cnd.0B013E31816F18E3 |
0.46 |
|
| 2007 |
Wolinsky JS, Narayana PA, O'Connor P, Coyle PK, Ford C, Johnson K, Miller A, Pardo L, Kadosh S, Ladkani D, Kastrukoff L, Duquette P, Freedman M, Debouverie M, Lubetski C, ... ... Sheremata W, et al. Glatiramer acetate in primary progressive multiple sclerosis: Results of a multinational, multicenter, double-blind, placebo-controlled trial Annals of Neurology. 61: 14-24. PMID 17262850 DOI: 10.1002/Ana.21079 |
0.339 |
|
| 2006 |
Sheremata WA, Jy W, Delgado S, Minagar A, McLarty J, Ahn Y. Interferon-beta1a reduces plasma CD31+ endothelial microparticles (CD31+EMP) in multiple sclerosis. Journal of Neuroinflammation. 3: 23. PMID 16952316 DOI: 10.1186/1742-2094-3-23 |
0.317 |
|
| 2006 |
Delgado S, Sheremata WA. The role of CD4+ T-cells in the development of MS. Neurological Research. 28: 245-9. PMID 16687048 DOI: 10.1179/016164106X98107 |
0.391 |
|
| 2005 |
Sheremata WA, Minagar A, Alexander JS, Vollmer T. The role of alpha-4 integrin in the aetiology of multiple sclerosis: current knowledge and therapeutic implications. Cns Drugs. 19: 909-22. PMID 16268663 DOI: 10.2165/00023210-200519110-00002 |
0.405 |
|
| 2005 |
O'Connor P, Miller D, Riester K, Yang M, Panzara M, Dalton C, Miszkiel K, Khan O, Rice G, Sheremata W, Barker GJ, MacManus DG, Webb C, Middleditch C, Lewis S, et al. Relapse rates and enhancing lesions in a phase II trial of natalizumab in multiple sclerosis Multiple Sclerosis. 11: 568-572. PMID 16193895 DOI: 10.1191/1352458505Ms1205Oa |
0.37 |
|
| 2004 |
Jy W, Minagar A, Jimenez JJ, Sheremata WA, Mauro LM, Horstman LL, Bidot C, Ahn YS. Endothelial microparticles (EMP) bind and activate monocytes: elevated EMP-monocyte conjugates in multiple sclerosis. Frontiers in Bioscience : a Journal and Virtual Library. 9: 3137-44. PMID 15353343 DOI: 10.2741/1466 |
0.364 |
|
| 2004 |
O'Connor PW, Goodman A, Willmer-Hulme AJ, Libonati MA, Metz L, Murray RS, Sheremata WA, Vollmer TL, Stone LA. Randomized multicenter trial of natalizumab in acute MS relapses: clinical and MRI effects. Neurology. 62: 2038-43. PMID 15184611 DOI: 10.1212/01.Wnl.0000128136.79044.D6 |
0.354 |
|
| 2003 |
Miller DH, Khan OA, Sheremata WA, Blumhardt LD, Rice GP, Libonati MA, Willmer-Hulme AJ, Dalton CM, Miszkiel KA, O'Connor PW. A controlled trial of natalizumab for relapsing multiple sclerosis. The New England Journal of Medicine. 348: 15-23. PMID 12510038 DOI: 10.1056/Nejmoa020696 |
0.397 |
|
| 2002 |
Minagar A, Sheremata WA, Weiner WJ. Transient movement disorders and multiple sclerosis. Parkinsonism & Related Disorders. 9: 111-3. PMID 12473401 DOI: 10.1016/S1353-8020(02)00009-3 |
0.374 |
|
| 2001 |
Minagar A, Shapshak P, Heyes M, Sheremata WA, Fujimara R, Ownby R, Goodkin K, Eisdorfer K. Microglia and Astrocytes in Neuro-Aids, Alzheimers Disease, and Multiple Sclerosis. Thescientificworldjournal. 1: 69. PMID 30147541 DOI: 10.1100/Tsw.2001.107 |
0.365 |
|
| 2001 |
Minagar A, Sheremata WA, Tusa RJ. Perverted head-shaking nystagmus: a possible mechanism. Neurology. 57: 887-9. PMID 11552022 DOI: 10.1212/Wnl.57.5.887 |
0.316 |
|
| 2001 |
Minagar A, Jy W, Jimenez JJ, Sheremata WA, Mauro LM, Mao WW, Horstman LL, Ahn YS. Elevated plasma endothelial microparticles in multiple sclerosis. Neurology. 56: 1319-24. PMID 11376181 DOI: 10.1212/Wnl.56.10.1319 |
0.326 |
|
| 2000 |
Minagar A, Sheremata WA. Glossopharyngeal neuralgia and MS. Neurology. 54: 1368-70. PMID 10746612 DOI: 10.1212/Wnl.54.6.1368 |
0.394 |
|
| 2000 |
Minagar A, Sheremata W, Vollmer T, Willmer-Hulme A, Koller M. Reduction of Relapses in Multiple Sclerosis after Anti-Alpha4 Integrin Antibody (Natalizumab) International Journal of Ms Care. 2: 2-5. DOI: 10.7224/1537-2073-2.1.2 |
0.355 |
|
| 1999 |
Sheremata WA, Vollmer TL, Stone LA, Willmer-Hulme AJ, Koller M. A safety and pharmacokinetic study of intravenous natalizumab in patients with MS. Neurology. 52: 1072-4. PMID 10102433 DOI: 10.1212/Wnl.52.5.1072 |
0.322 |
|
| 1997 |
Elgart GW, Sheremata W, Ahn YS. Cutaneous reactions to recombinant human interferon beta-1b: The clinical and histologic spectrum Journal of the American Academy of Dermatology. 37: 553-558. PMID 9344192 DOI: 10.1016/S0190-9622(97)70170-1 |
0.313 |
|
| 1997 |
Nance PW, Sheremata WA, Lynch SG, Vollmer T, Hudson S, Francis GS, O'Connor P, Cohen JA, Schapiro RT, Whitham R, Mass MK, Lindsey JW, Shellenberger K. Relationship of the antispasticity effect of tizanidine to plasma concentration in patients with multiple sclerosis. Archives of Neurology. 54: 731-6. PMID 9193208 DOI: 10.1001/Archneur.1997.00550180049011 |
0.388 |
|
| 1995 |
Sheremata WA, Taylor JR, Elgart GW. Severe necrotizing cutaneous lesions complicating treatment with interferon beta-1b. The New England Journal of Medicine. 332: 1584. PMID 7739724 DOI: 10.1056/Nejm199506083322316 |
0.31 |
|
| 1995 |
Harrington WJ, Ucar A, Gill P, Snodgrass S, Sheremata W, Cabral L, Rabin M, Byrne GE, Berger J, Voight W. Clinical spectrum of HTLV-I in south Florida. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association. 8: 466-73. PMID 7697443 DOI: 10.1097/00042560-199504120-00006 |
0.361 |
|
| 1992 |
Honig LS, Ramsay RE, Sheremata WA. Event-related potential P300 in multiple sclerosis. Relation to magnetic resonance imaging and cognitive impairment. Archives of Neurology. 49: 44-50. PMID 1728263 DOI: 10.1001/Archneur.1992.00530250048015 |
0.328 |
|
| 1992 |
Sheremata WA, Berger JR, Harrington WJ, Ayyar DR, Stafford M, DeFreitas E. Human T lymphotropic virus type I-associated myelopathy. A report of 10 patients born in the United States. Archives of Neurology. 49: 1113-8. PMID 1444875 DOI: 10.1001/Archneur.1992.00530350027014 |
0.341 |
|
| 1992 |
Berger JR, Tornatore C, Major EO, Bruce J, Shapshak P, Yoshioka M, Houff S, Sheremata W, Horton GF, Landy H. Relapsing and remitting human immunodeficiency virus-associated leukoencephalomyelopathy. Annals of Neurology. 31: 34-8. PMID 1311910 DOI: 10.1002/Ana.410310107 |
0.339 |
|
| 1991 |
Harrington WJ, Sheremata WA, Snodgrass SR, Emerson S, Phillips S, Berger JR. Tropical spastic paraparesis/HTLV-1-associated myelopathy (TSP/HAM): treatment with an anabolic steroid danazol. Aids Research and Human Retroviruses. 7: 1031-4. PMID 1812944 DOI: 10.1089/Aid.1991.7.1031 |
0.347 |
|
| 1989 |
Berger JR, Sheremata WA, Resnick L, Atherton S, Fletcher MA, Norenberg M. Multiple sclerosis-like illness occurring with human immunodeficiency virus infection. Neurology. 39: 324-9. PMID 2927638 DOI: 10.1212/Wnl.39.3.324 |
0.383 |
|
| 1988 |
Jacobson S, Zaninovic V, Mora C, Rodgers-Johnson P, Sheremata WA, Gibbs CJ, Gajdusek C, McFarlin DE. Immunological findings in neurological diseases associated with antibodies to HTLV-I: activated lymphocytes in tropical spastic paraparesis. Annals of Neurology. 23: S196-200. PMID 2894814 DOI: 10.1002/Ana.410230744 |
0.379 |
|
| 1988 |
Honig LS, Siddharthan R, Sheremata WA, Sheldon JJ, Sazant A. Multiple sclerosis: correlation of magnetic resonance imaging with cerebrospinal fluid findings. Journal of Neurology, Neurosurgery, and Psychiatry. 51: 277-80. PMID 2450176 DOI: 10.1136/Jnnp.51.2.277 |
0.376 |
|
| 1987 |
Román GC, Sheremata WA. Multiple sclerosis (not tropical spastic paraparesis) on Key West, Florida. Lancet. 1: 1199. PMID 2883504 DOI: 10.1016/S0140-6736(87)92161-1 |
0.389 |
|
| 1985 |
Sheldon JJ, Siddharthan R, Tobias J, Sheremata WA, Soila K, Viamonte M. MR imaging of multiple sclerosis: comparison with clinical and CT examinations in 74 patients. Ajr. American Journal of Roentgenology. 145: 957-64. PMID 3876753 DOI: 10.2214/Ajr.145.5.957 |
0.417 |
|
| 1985 |
Koprowski H, DeFreitas EC, Harper ME, Sandberg-Wollheim M, Sheremata WA, Robert-Guroff M, Saxinger CW, Feinberg MB, Wong-Staal F, Gallo RC. Multiple sclerosis and human T-cell lymphotropic retroviruses. Nature. 318: 154-60. PMID 2997627 DOI: 10.1038/318154A0 |
0.369 |
|
| 1985 |
Berger JR, Sheremata WA. Neurological Deficits Following the Hot Bath Test in Multiple Sclerosis-Reply Jama. 253: 203-203. DOI: 10.1001/Jama.1985.03350260049025 |
0.4 |
|
| 1984 |
Berger JR, Sheremata WA, Melamed E. Paroxysmal dystonia as the initial manifestation of multiple sclerosis. Archives of Neurology. 41: 747-50. PMID 6743065 DOI: 10.1001/Archneur.1984.04050180069020 |
0.433 |
|
| 1983 |
Berger JR, Sheremata WA. Persistent neurological deficit precipitated by hot bath test in multiple sclerosis. Jama. 249: 1751-3. PMID 6600798 DOI: 10.1001/Jama.1983.03330370061034 |
0.316 |
|
| 1983 |
Berger JR, Rosenfeld WE, Sheremata WA, Lian EC, Ayyar DR, Melo J, Kloss K. Chronic inflammatory polyradiculoneuropathy complicated by factor VIII antibody. Neurology. 33: 1224-6. PMID 6412159 DOI: 10.1212/Wnl.33.9.1224 |
0.308 |
|
| 1982 |
Berger JR, Sheremata W. The hot bath test and multiple sclerosis. Jama. 247: 979-979. DOI: 10.1001/Jama.1982.03320320019015 |
0.406 |
|
| 1976 |
Allen JC, Sheremata W, Cosgrove JBR, Osterland K, Shea M. Cerebrospinal fluid T and B lymphocyte kinetics related to exacerbations of multiple sclerosis Neurology. 26: 579-579. PMID 1084494 DOI: 10.1212/Wnl.26.6.579 |
0.361 |
|
| 1975 |
Sheremata W, Colby S, Lusky G, Cosgrove JBR. Cellular hypersensitization to peripheral nervous antigens in the Guillain-Barré syndrome Neurology. 25: 833-839. PMID 1099473 DOI: 10.1212/Wnl.25.9.833 |
0.329 |
|
| 1973 |
Benson DF, Sheremata WA, Bouchard R, Segarra JM, Price D, Geschwind N. Conduction aphasia. A clinicopathological study. Archives of Neurology. 28: 339-46. PMID 4696016 DOI: 10.1001/Archneur.1973.00490230075011 |
0.315 |
|
| 1971 |
Rocklin RE, Sheremata WA, Feldman RG, Kies MW, David JR. The Guillain-Barré syndrome and multiple sclerosis. In vitro cellular responses to nervous-tissue antigens. The New England Journal of Medicine. 284: 803-8. PMID 4323673 DOI: 10.1056/Nejm197104152841501 |
0.364 |
|
| Show low-probability matches. |